Key Takeaways

• Johnson & Johnson will host and participate in peer-to-peer educational programs at ESCRS 2026 covering refractive surgery, presbyopia treatment, cataract care, IOL selection, and biometry
• Investigator-initiated and independent studies will present clinical data on the Tecnis IOL portfolio, including Tecnis Odyssey, Tecnis PureSee, and Tecnis Eyhance, across patient populations and surgical settings

To support ophthalmologists in optimizing patient outcomes and advancing clinical practice, Johnson & Johnson will host and participate in a series of peer-to-peer educational programs featuring leading ophthalmic surgeons and key opinion leaders throughout the 2026 European Society of Cataract and Refractive Surgery (ESCRS) Congress, September 11-15 in London.

"Through symposia, expert panel discussions, case-based learning and interactive sessions, attendees will gain insights into the latest evidence, technologies and real-world clinical experiences across refractive surgery, presbyopia treatment and cataract care", said Lisa Ann Hill, President EMEA, Vision, MedTech, Johnson & Johnson. "Investigator initiated data will also be presented at ESCRS reflecting the growing body of clinical evidence supporting the TECNIS IOL portfolio across a range of patient needs."

Peer-to-Peer Education Events  

Johnson & Johnson is hosting and participating in educational sessions with key opinion leaders throughout the meeting: 

Saturday, September 12:

• 10:30-11:00: Meet the Experts: Real Cases, Real Choices: The Truth Behind Tecnis Odyssey IOL
  • ExCeL Exhibition Centre, London - Booth E.200
  • Expert perspectives on optimizing clinical outcomes with Tecnis Odyssey IOL. Three experienced surgeons will share their strategies for patient selection, decision making, and real-world case insights, with the session moderated by an expert surgeon to ensure an interactive discussion for the audience.
• 13:00-14:00: Lunch Symposia: Advancing Full Range of Vision: Evidence, Experience and Outcomes with Tecnis Odyssey IOL
  • ExCeL Exhibition Centre, London - Level 3 Victoria Room 5/6
  • Valuable opportunity to explore Tecnis Odyssey IOL - through the personal clinical experiences of leading ophthalmic surgeons, moderated by Prof. Oliver Findl
• 15:30-16:00: Meet the Experts: The Art of Precision: Tecnis PureSee IOL Through Expert Eyes
  • ExCeL Exhibition Centre, London - Booth E.200
  • Expert perspectives on optimizing clinical outcomes with Tecnis PureSee IOL. Experienced surgeons share their strategies for patient selection, surgical planning, and real-world case insights. The session concludes with an interactive Q&A.

Sunday, September 13:

• 8:30-10:00: ESCRS European Clinical Spotlight Symposium Session 2026: Multicentric Randomized Clinical Trial comparing the refractive Extended Depth of focus IOL, Tecnis PureSee, vs an aspheric monofocal control, Tecnis 1 piece IOL
  • ExCeL Exhibition Centre, London - ICC Auditorium
  • Presentation will reinforce clinical trial data, demonstrating the clinical safety and effectiveness of the Tecnis PureSee IOL
    • A sub-group analysis will be shared showing results of subjects with absolute post-op spherical equivalent (SEQ) > 0.25 D in one or both eyes to assess the tolerance of the study IOL to post op refractive error
       
• 10:30-11:00: Meet the Experts: SILK in Action: See It. Learn It. Master It.
  • ExCeL Exhibition Centre, London - Booth E.200
  • Learn about the SILK procedure, from surgical technique and pre-operative planning, to learning curve management and real-world case insights from experienced surgeons.
     
•  13.00-14.00: Lunch Symposia: From Enhanced to Extended: Shaping the Modern IOL Spectrum
  • ExCeL Exhibition Centre, London - Level 3 - George V Room 4
  • Valuable opportunity to explore Tecnis Eyhance IOL & Tecnis PureSee IOL — through the personal clinical experiences of leading ophthalmic surgeons, moderated by Dr. Ahmed Assaf
• 15:30-16:15: Biometry Excellence Master Class
  • ExCeL Exhibition Centre, London - Booth E.200
  • This Biometry Excellence Master class translates biometry science into actionable steps to consistently achieve more predictable, patient‑satisfying results. During this session our experts will share practical guidance on formula selection and plausibility checks to reduce refractive surprises, particularly in short, long and complex eyes.

Johnson & Johnson is also proud to support the ESCRS Corneal and Lens-Based Refractive Surgery Masterclass, a new global educational initiative designed to help develop the next generation of refractive surgeons. Combining expert mentorship, virtual learning, case-based discussions and hands-on training, the programme provides early-career ophthalmologists with the knowledge and skills to advance excellence in refractive patient care.

Notable findings for the TECNIS Family of IOLs: 

Tecnis IOLs are prominently featured across papers and posters at ESCRS, with highlighted Investigator Initiated Studies demonstrating strong, high‑quality visual outcomes, including in post‑LASIK patient populations and refractive lensectomy.

• Visual And Refractive Outcomes of an EDOF Intraocular Lens in Post-Lasik Eyes Vs Non-Lasik Controls: A Real-World Retrospective Comparison – Presented by: Dr. David Mingo Botín*
• Patients achieved a high level of visual acuity and refractive outcomes Tecnis 
  • Refractive accuracy showed that 93% of post-LASIK eyes and 77% of control eyes were within ±0.50 
  • Monocular UDVA 20/24 (0.07) in the post-LASIK group versus 20/23 (0.05) in controls
• Prospective Evaluation Of Visual And Refractive Outcomes With TECNIS PureSee IOL (Partial Dofi-Ex) Intraocular Lens – Presented by: Dr Clare O'Donnell on behalf of Dr Alise Kalteniece*
  • This study reports the visual and refractive outcomes of TECNIS PureSee IOL intraocular lens implanted bilaterally following refractive lensectomy
    • Mean binocular UDVA was 20/19 (-0.02), binocular UIVA was 20/27 (0.14)
    • All respondents reported improved postoperative scores in Catquest-9SF questionnaire 
• Visual And Functional Outcomes of the TECNIS Odyssey Full-Dofi Intraocular Lens – Presented by: Dr. Nic J. Reus*
  • Bilateral implantation of TECNIS Odyssey IOL demonstrated a continuous range of high-quality vision across all distances
    • Binocular UDVA and CDVA were both 20/14 (-0.16)
    • Binocular UIVA and DCIVA were 20/21(0.02) and 20/17 (-0.06), respectively
    • Binocular UNVA and DCNVA were 20/19 (-0.02) and 20/18 (-0.04), respectively
• Clinical Outcomes of a New Full Range Diffractive Intraocular Lens – Presented by: Dr. Helena Noguera Nuñez*
  • TECNIS Odyssey IOL demonstrated strong visual outcomes across far, intermediate, and near distances, with good refractive performance and high patient satisfaction
    • Mean CDVA and DCIVA at 3 months were 20/20 (0.0)
    • DCNVA was 20/25 (0.1)
• Comparison Of Vision, Spectacle Independence and Patient Satisfaction with Micro-Monovision Implantation of Two Toric Aspheric Intraocular Lenses in the Public Health Sector: Final Results of a Prospective Randomized Controlled Study – Presented by: Dr. Ashmal Jameel and Prof David O’Brart*
  • Eyhance Toric IOL showed greater spectacle independence, compared to Acrysof IQ Toric
  • 65% of TECNIS Eyhance IOL patients versus 20% of Acrysof IQ patients reported independence from glasses, despite similar distance vision between groups

TECNIS IOLs will also be featured via independent studies:

• Visual Outcomes After Bilateral TECNIS PureSee IOL Implantation in Refractive Lens Exchange Patients with Ocular

Morbidities: A Multicentre Retrospective Cohort Study – Presented by: Dr. Frank Kerkhoff

• Enhancement Rates Across Full Range Of Focus IOL Platforms – Presented by: Dr. Frank Kerkhoff
• Visual And Refractive Outcomes Following Implantation of a Refractive Partial Range of Field Extended Intraocular Lens in Eyes with a History of Previous Laser Refractive Surgery – Presented by: Dr. Richard Mcneely